Product Information
BRINZOLAMIDE 1% EYE DROPS is a generic product labeled by Oceanside Pharmaceuticals, priced at $10.3789 per ML under NDC 68682046410. Its NADAC has been published 183 times since Apr 6, 2022.
FDA first approved this application on Aug 18, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/mL
Manufacturer
Oceanside PharmaceuticalsNDC
68682046410
Classification
Generic
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
9/17/2025
Active Ingredients
BRINZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204884FDA Approved
8/18/2021
TE Code
AB
On Market Since
8/25/2021
Pharmacological Classes
Price Statistics
The NADAC for BRINZOLAMIDE 1% EYE DROPS has been published 183 times since Apr 6, 2022, and over the history we have for it it has declined 61.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $10.3789 per ML |
|---|---|
| All-time high | $26.8459 (Apr 13, 2022) |
| All-time low | $10.2802 (Apr 17, 2024) |
| 52-week high | $11.1820 |
| 52-week low | $10.3789 |
| Median price | $15.2611 |
| Average price | $16.0585 |
| Largest weekly change | +26.9% (Aug 21, 2024) |
| Weeks tracked | 183 |
| Tracking since | Apr 6, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-7.2%
3Y
-38.8%
5Y
N/A
All
-61.3%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BRINZOLAMIDE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for BRINZOLAMIDE 1% EYE DROPS, manufactured by Oceanside Pharmaceuticals, is $10.3789 per ML (NDC 68682046410), effective Oct 1, 2025.
How has the price of BRINZOLAMIDE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for BRINZOLAMIDE 1% EYE DROPS has declined 61.3%. It has been tracked across 183 weekly CMS publications since Apr 6, 2022.
What are the highest and lowest recorded NADAC prices for BRINZOLAMIDE 1% EYE DROPS?
Since Apr 6, 2022, the NADAC for BRINZOLAMIDE 1% EYE DROPS has ranged from a low of $10.2802 (Apr 17, 2024) to a high of $26.8459 (Apr 13, 2022), with a median of $15.2611 per ML.
Are there cheaper alternatives to BRINZOLAMIDE 1% EYE DROPS?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BRINZOLAMIDE 1% EYE DROPS, is $9.4893 per ML — about 9% below BRINZOLAMIDE 1% EYE DROPS.
Who manufactures BRINZOLAMIDE 1% EYE DROPS?
BRINZOLAMIDE 1% EYE DROPS (NDC 68682046410) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.